Rational Design, Synthesis, and Pharmacological Properties of New 1,8-Naphthyridin-2(1H)-on-3-Carboxamide Derivatives as Highly Selective Cannabinoid-2 Receptor Agonists-Reference-Cited by-同舟云学术

Rational Design, Synthesis, and Pharmacological Properties of New 1,8-Naphthyridin-2(1H)-on-3-Carboxamide Derivatives as Highly Selective Cannabinoid-2 Receptor Agonists

Published:2009-05-12 Issue:12 Volume:52 Page:3644-3651
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Manera Clementina¹,Saccomanni Giuseppe¹,Adinolfi Barbara¹,Benetti Veronica¹,Ligresti Alessia¹,Cascio Maria Grazia¹,Tuccinardi Tiziano¹,Lucchesi Valentina¹,Martinelli Adriano¹,Nieri Paola¹,Masini Emanuela¹,Di Marzo Vincenzo¹,Ferrarini Pier Luigi¹

Affiliation:

1. Dipartimento di Scienze Farmaceutiche and Dipartimento di Psichiatria, Neurobiologia, Farmacologia e Biotecnologie, Università di Pisa, Via Bonanno 6, 56126 Pisa, Italy, Dipartimento di Farmacologia Preclinica e Clinica, Università di Firenze, Viale G. Pieraccini 6, 50139 Firenze, Italy, Endocannabinoid Research Group, Istituto di Chimica Biomolecolare, Consiglio Nazionale delle Ricerche, Via Campi Flegrei 34, 80078 Pozzuoli, Napoli, Italy, and Sbarro Institute for Cancer Research and Molecular Medicine,...

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm801563d

Reference40 articles.

1. The Endocannabinoid System: Drug Targets, Lead Compounds, and Potential Therapeutic Applications

2. Targeting the endocannabinoid system: to enhance or reduce?

3. Evidence for novel cannabinoid receptors

4. Indoles and Related Compounds as Cannabinoid Ligands

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synthesis, design, and antiproliferative evaluation of 6-(N-Substituted-methyl)pyrazolo[3,4-d]pyrimidines as the potent anti-leukemia agents;Bioorganic Chemistry;2024-07

2. Synthesis, Structure–Activity Relationships, Radiofluorination, and Biological Evaluation of [¹⁸F]RM365, a Novel Radioligand for Imaging the Human Cannabinoid Receptor Type 2 (CB2R) in the Brain with PET;Journal of Medicinal Chemistry;2023-10-10

3. Novel Cannabinoid Receptor 2 (CB2) Low Lipophilicity Agonists Produce Distinct cAMP and Arrestin Signalling Kinetics without Bias;International Journal of Molecular Sciences;2023-03-29

4. Design, synthesis and biological evaluation of novel orthosteric-allosteric ligands of the cannabinoid receptor type 2 (CB2R);Frontiers in Chemistry;2022-09-27

5. Structure-Based Design, Optimization, and Development of [¹⁸F]LU13: A Novel Radioligand for Cannabinoid Receptor Type 2 Imaging in the Brain with PET;Journal of Medicinal Chemistry;2022-06-30